Gene expression profiling to predict response to neoadjuvant docetaxel and capecitabine for breast cancer

被引:0
|
作者
Korde, L.
Zujewski, J.
McShane, L.
Lukes, L.
Lebowitz, P.
Swain, S.
Finney, R.
Hunter, K.
机构
[1] Natl Canc Inst, Bethesda, MD USA
[2] NCI, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:119 / 119
页数:1
相关论文
共 50 条
  • [31] Gene expression profiling in breast cancer
    Morris, Shannon R.
    Carey, Lisa A.
    CURRENT OPINION IN ONCOLOGY, 2007, 19 (06) : 547 - 551
  • [32] Expression profiles can predict specific responses of capecitabine/docetaxel (C/D) based primary systemic therapy in breast cancer (BC) patients receiving neoadjuvant therapy
    Perou, C.
    Moisa, C.
    Gulick, S.
    Tripathy, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] Gene Expression Profiling in Breast Cancer
    Turaga, Kiran
    Acs, Geza
    Laronga, Christine
    CANCER CONTROL, 2010, 17 (03) : 177 - 182
  • [34] Gene expression profiling in breast cancer
    Arango, Belisario A.
    Rivera, Celine L.
    Glueck, Stefan
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2013, 5 (02): : 132 - 138
  • [35] Gene expression profiling in breast cancer
    Sotiriou, C.
    Desmedt, C.
    ANNALS OF ONCOLOGY, 2006, 17 : X259 - X262
  • [36] Gene expression profiling of breast cancer
    Lajos Pusztai
    Breast Cancer Research, 11
  • [37] Gene expression profiling of breast cancer
    Van de Vinver, M.
    EJC SUPPLEMENTS, 2008, 6 (09): : 67 - 67
  • [38] Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
    Yen-Shen Lu
    Dar-Ren Chen
    Ling-Min Tseng
    Dah-Cherng Yeh
    Shou-Tung Chen
    Chia-Ming Hsieh
    Hwei-Chung Wang
    Hsien-Tang Yeh
    Sung-Hsin Kuo
    Chiun-Sheng Huang
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1257 - 1263
  • [39] Capecitabine and docetaxel combination for the treatment of breast cancer
    Morishita, Mariko
    Leonard, Robert C.
    WOMENS HEALTH, 2008, 4 (01) : 11 - 22
  • [40] Semi-quantitative gene expression profiling for therapy prediction in a breast cancer neoadjuvant therapy study applying docetaxel/epirubicin/cyclophosphamide (TEC)
    Vogt, U.
    Schlotter, C. M.
    Bosse, U.
    Bonk, U.
    Brandt, B. H.
    EJC SUPPLEMENTS, 2006, 4 (06): : 49 - 50